Conventus Orthopaedics’ DRS Implant Receives FDA Clearance

Conventus Orthopaedics has received FDA 510(k) clearance for its Conventus DRS Implant to treat distal radius fractures.

Advertisement

The implant is designed to be less invasive for orthopedic surgeons, according to the release. Surgeons can treat a bread range of distal radius fractures without sacrificing stability.

The device also underwent a clinical study in Europe.

More Articles on Devices:
Johnson & Johnson’s Synthes Acquisition Adds 5.6% 4Q Sales Growth
Stryker Reports 4.2% Net Sales Growth in 2012, Hampered by $133M in Recall Charges
Smith & Nephew Wound Device Could Lower Healthcare Costs

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Watch On-Demand Webinar

ASC development + private equity: How to build value from day one

Presenters: Andrew HrankaWendy Bruno Thomson, MBA, LHARichard Romero, CVA, ABV, FHFMA, PAHM

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.